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Abstract 10 
Microfluidic ultrahigh-throughput screening of enzyme activities provides information on libraries 
with millions of variants in a day. Each individual library member is represented by a recombinant 
single cell, compartmentalised in an emulsion droplet, in which an activity assay is carried out. Key to 
the success of this approach is the precision and sensitivity of the assay. Assay quality is most 
profoundly challenged when initially weak, promiscuous activities are to be enhanced in early rounds 15 
of directed evolution or when entirely novel catalysts are to be identified from metagenomic sources. 
Implementation of measures to widen the dynamic range of clonal assays would increase the chances 
of finding and generating new biocatalysts. Here, we demonstrate that the assay sensitivity and DNA 
recovery can be improved by orders of magnitude by growth of initially singly compartmentalised cells 
in microdroplets. Homogeneous cell growth is achieved by continuous oxygenation and recombinant 20 
protein expression is regulated by diffusion of the inducer from the oil. Reaction conditions are 
adjusted by directed droplet coalescence to enable full control of buffer composition and kinetic 
incubation time, creating level playing field conditions for library selections. The clonal amplification 
multiplies the product readout because more enzyme is produced per compartment. At the same 
time, phenotypic variation is reduced by measuring monoclonal populations rather than single cells 25 
and recovery efficiency is increased. Consequently, this workflow increases the efficiency of lysate-
based microfluidic enzyme assays and will make it easier for protein engineers to identify or evolve 




Enzymes are increasingly used for sustainable chemical synthesis, as they are powerful ‘green’ 
catalysts providing efficient turnover and remarkable stereo- and enantioselectivity under mild 
reaction conditions.1,2 If a reaction that does not exist in Nature is to be catalysed, there are two 
principal routes to enzymes with novel activities: either natural enzymes with secondary, promiscuous 35 
activities3–5 are fine-tuned to the requisites of industrial processes, often via directed evolution. 
Alternatively, new enzyme functions can either be discovered by functional metagenomics in large 
samples of natural biodiversity6–10 or introduced by computational design.11–13 In all cases, the initially 
weak activity of an enzyme is likely to require improvements and directed evolution is usually the 
method of choice. This artificial Darwinian process consists of repeated cycles of mutagenesis and 40 
selection and has led to many successful biocatalysts.14–16 The prospects of directed evolution 
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campaigns, however, improve with the practical ability to explore greater diversity via ever higher 
throughput screening approaches. In the last decade, compartmentalisation of single library members 
and miniaturisation of reaction volumes in droplet microfluidics (see Fig. 1) has proven a valuable and 
efficient tool for enzyme evolution.17,18 Single library members (e.g. cells expressing19 or displaying20 45 
enzyme variants) are co-encapsulated with the substrate and reaction progress is followed in 
chromogenic or fluorogenic reactions by optical interrogation of droplet-compartmentalised library 
members. Droplets can be sorted with kHz frequencies, enabling fast screening of tens of millions of 
variants in a day, in picoliter volumes.19–21  
In addition to maximal throughput, the dynamic range and sensitivity of the assay (including the 50 
analytical technologies for measuring product concentrations) are key features relevant for success. 
Indeed, concentrations of fluorescent reaction product as low 2.5 nM could be detected in a 
metagenomic screening of hydrolases, corresponding to just ~2500 molecules of the reaction product 
fluorescein in 2 pL droplets.6 Consequently, even hits with relatively low activities (kcat/KM ~50 M-1s-1) 
could be identified. This means the sensitivity of droplet screening is increased by several orders of 55 
magnitude compared to e.g. conventional plate screening, so that metagenomic hits with inefficient 
expression and/or low promiscuous activities can be discovered or subsequently evolved in droplets. 
However, for very low promiscuous activities or enzymes from metagenomic libraries with low 
expression, detection limits may still preclude catalyst discovery. The superb sensitivity afforded by 
fluorescence detection is difficult to match when other optical assays that involve detection of product 60 
absorbance22 or anisotropy23 are used, where detection limits of 10 µM and 0.1 µM, respectively, have 
been determined. Other non-optical detection modes have recently been applied to assay enzymatic 
activity and enabled detection limits in a similar range to the new optical methods, e.g. 1 µM for 
electrochemical24 and 30 µM for mass spectrometric25 detections. In any case, a crucial condition in 
all droplet approaches is the necessity to compartmentalise, by Poisson-distribution, just one cell (or 65 
gene) per droplet compartment. This renders the droplet monoclonal, i.e. defined by just one unique 
DNA sequence. On the other hand, while necessary for monoclonality, compartmentalisation of single 
cells imposes limits on the amount of enzyme produced that is in turn leading to formation of 
detectable product. A larger enzyme concentration would make it easier to detect reaction product, 
which means that low promiscuous activity or only weakly expressed enzymes (e.g. in metagenomic 70 
libraries) can be identified and become selectable.  
Here we establish a general workflow (Fig. 1) that addresses the problem of detection limits in droplet 
screening by facilitating homogeneous cell growth in droplet compartments, resulting in increased 
enzyme content per droplet. We show that the individual enzyme performance necessary for 
successful product detection is lowered ~10-fold. We validate the workflow by demonstrating its 75 
applicability to the conversion of an amino acid dehydrogenase to an amine dehydrogenase 




Fig. 1: Overview of cell lysate screening after growth-amplification in comparison to standard single cell 80 
activity assays. In each case, E. coli cells are transformed with a plasmid library for expression of enzyme 
variants. These cells are then Poisson-distributed in microfluidic droplets, so that the majority of droplets has 
one or no cell (‘monoclonal droplets’). A) Conventional single cell lysate assay: bulk cell growth and protein 
expression (A.1). The cell suspension (A.2 a) is then co-encapsulated with substrate and lysis agent (A.2 b) at the 
point of droplet formation. After allowing time for sufficient enzymatic turnover to reach a detectable signal, 85 
the droplets are sorted on a microfluidic chip. B) Clonal amplification in droplets for enzyme lysate assays: to 
amplify the signal in microfluidic enzyme assays, single cells are encapsulated and grown in droplets (B.1). 
Droplets are incubated under oil flow (grey) to allow for homogeneous cell growth as well as protein expression 
(B.2). Substrate and lysis agent (B.3 b) are added to the droplets (B.3 a) in a second step via selective droplet 
coalescence (B.3) and subsequently sorted on a microfluidic chip. 90 
 
 
Results and Discussion 
Achieving homogeneous cell growth in droplets 
First, a suitable device for droplet incubation needed to be prepared that allows for robust storage 95 
and convenient handling of emulsions, such as direct re-injection into a sorting device. For this 
purpose, modified 0.5 mL reaction tubes were used (Fig. 2A, Fig. S1). These droplet incubation 
chambers can easily be prepared by opening access holes into a standard plastic reaction tube with a 
biopsy punch and attaching access tubing with high-viscosity plastic glue. The droplets are directly 
collected from the generation device into such a chamber pre-filled with oil. During incubation the 100 
droplets packed at the top of the oil in the chamber, allowing for a convenient and robust way to 
incubate large emulsion volumes without destabilization by surface effects and for easy re-injection 
into subsequent microfluidic devices, as necessary for extensive microfluidic screening campaigns.  
Next, cell growth was established in these incubation chambers. To test the hypothesis that oxygen 
availability is key to homogeneous growth, static and oxygenated cell growth in droplets was 105 
compared. A live cell stain compatible with absorbance-activated droplet sorting (AADS) was found in 
WST-1 that was injected into the droplets after growth. WST-1 absorbance also changes concomitantly 
with reduction of NAD+ in a coupled reaction.22 Amplification of cells in droplets was first tested in the 
most straightforward format, by encapsulating single cells into droplets filled with growth medium 
and incubation at 37°C for 16 h without any oxygenation or mixing. Occupied droplets (empty droplets 110 
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are ignored) incubated under these static growth conditions showed a main peak at low absorbance 
values with a very strong tail (Fig. 2B), indicating that most droplets show little growth amplification 
whereas few droplets (showing up in the tail) provide conditions for higher cell growth, resulting in a 
mixed population. We sought to establish homogeneity in the droplet population by pushing oil 
through the incubation chamber, thus providing gentle mixing and oxygen supply. When relatively low 115 
oil flow rates for oxygenation (4 µL min-1 per 100 µL of emulsion) were used, homogeneous cell growth 
could be achieved. To quantify the effect of oxygenation on the growth homogeneity of the 
population, a robust measure of scale, the interquartile range, was used. This was necessary because 
of the non-normality of the static growth distribution: droplets with ‘extreme’ growth values, by 
convention defined as outliers with an absorbance greater than the third quartile plus 1.5-fold 120 
interquartile range (0.35% for a reference normal distribution), are abundant in static growth 
conditions, resulting in 12.1% of the total number of droplets being ‘extreme’ outliers. When 
oxygenation was applied, the peak of occupied droplets showed a reduction to a mere 1.1% droplets 
with extreme growth, quantifying the beneficial effect of oxygenation on growth homogeneity by 
removing overly grown outliers.  125 
This situation that static cell growth in droplets, as demonstrated in previous studies,27–30 did not lead 
to fast growth amplification and homogeneity is unsatisfactory for precise assays: growth 
homogeneity is crucial for reliable screening, because identical conditions in every droplet are 
necessary to provide a quantitative readout of enzymatic turnover. The number of cells per droplet 
determines the enzyme concentration proportionally, thus influencing the enzymatic activity on which 130 
selections are based. Previous screening campaigns (e.g. with selections for antimicrobial resistance31 
or with initial filtering for cell growth by assessment of light scattering properties in flow cytometry32) 
were based on simple binary or merely qualitative selections, where different degrees of activity were 
not differentiated. As a consequence, they may not share the same sensitivity to growth homogeneity 
as screens for catalytic turnover. A possible reason for the homogeneity in static growth conditions is 135 
differential oxygen availability depending on the location of individual droplet in the device. While 
oxygen can diffuse into the emulsion from the oil, it is also rapidly depleted by the growing cells. As a 
result, the cell growth is not only reduced, but – as the availability of oxygen is greater in droplets 
close to the surface – heterogeneity is introduced dependent on a droplet’s position in the incubation 
chamber (Fig. 2C). The work of Mahler and colleagues33 has come to a similar conclusion. In their work 140 
a custom 3D-printed droplet incubation device was used for oxygenation of cells growing within 
droplets in a circular set-up, in which a peristaltic pump is used to push oil through an emulsion at 
high flow rates, to supply a maximal amount of oxygen. Our simple set-up does not yield the cell 
growth rates comparable to regular shaking flasks achieved by Mahler et al.,33 yet oxygenation with 
comparatively low oil flow rates provides growth homogeneity. This set-up requires only regular 145 




Fig. 2: Oxygen supply via the oil phase ensures rapid and homogeneous cell growth in droplets. A) Schematic 
of a droplet incubation chamber, built from a standard 0.5 mL plastic reaction tube, high viscosity glue and 150 
polyethylene tubing. These chambers allow for robust storage and convenient handling of droplet emulsions, 
which pack on top of the oil phase in the chamber. Droplets can easily be collected, stored, oxygenated and 
ejected from an incubation chamber. B) Histograms of occupied droplets (n = 2500) starting from singly 
compartmentalised E. coli that are grown in static (gray) or actively oxygenated (blue, 4 µl/min HFE-7500 with 
1% RAN surfactant) culture for 16 hours at 37°C. Cell growth was measured via the absorbance of the live cell 155 
stain formazan dye WST-1 (that detects NADH) and analysed in AADS.22 The upper fence of the corresponding 
boxplot for the static culture (corresponding to the third quartile plus 1.5-fold interquartile range) is marked 
with an asterisk and an arrow, and the static growth distribution beyond this point is coloured in red, highlighting 
the strong tail of the distribution. C) Illustrative scenarios for distribution of oxygen throughout a droplet sample 
during incubation for cell growth. Oxygenation by oil flow (left) leads to a homogeneous distribution, whereas a 160 
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lack of active oxygenation leads to oxygen depletion in the central, static population (right) with little mixing and 
exchange. 
 
Induction of recombinant protein expression without droplet manipulation 
In order to carry out enzyme assays in directed evolution, recombinant protein expression must be 165 
induced for each member of a gene library (coding for enzyme mutants or a metagenomic collection 
of proteins). Many protein expression systems rely on the addition of an external inducer after an 
initial growth phase, such as the T7 expression system34,35 present in the pET vector family. Here, 
recombinant expression is usually induced indirectly by the non-hydrolysable lactose analog IPTG 
(inducing expression of the T7 RNA polymerase via a lactose promoter, which then expresses the gene 170 
of interest via the T7 promoter), allowing control over the timing and extent of the induction.36 In a 
single cell lysate assay, protein expression can be induced in bulk culture before encapsulation. By 
contrast, when cell growth is performed for signal amplification, protein expression must be induced 
after encapsulation and growth in each individual droplet compartment. This poses a challenge to 
conventional induction systems, as an additional step is required to add the inducer, increasing 175 
workload and potentially endangering droplet stability. Therefore, a protein expression system 
offering similarly good control over cell count and protein expression efficiency without the need for 
an additional droplet manipulation step was investigated. 
Protein expression was studied in a model system by taking advantage of the easy visualisation of the 
oxygen-independent fluorescent protein iLOV37 with different induction systems in E. coli BL21 (DE3). 180 
(i) Firstly, auto-induction of the aforementioned T7 expression system in a medium containing glucose 
and lactose was investigated, because it promises expression from the T7 promoter without the 
external addition of an inducer. Glucose inhibits the recombinant protein expression in the early 
growth phase, but once it is metabolised the remaining lactose induces protein expression.38 This set-
up successfully led to protein expression in droplets (Fig. 3). However, finding the concentrations of 185 
glucose and lactose required for optimal protein production, as well as incubation times for strong 
expression proved challenging, as conditions from bulk culture were not directly transferable to 
droplet culture.  
(ii) Secondly, more straightforward constitutive expression was tested. Expression under control of 
the constitutive lacI promoter showed increased green fluorescence, while the number of cells per 190 
droplet increased dramatically. This can be an issue for many enzyme assays, including the one chosen 
as a model in this study, because of unspecific background activity from cellular components, in this 
case due to intracellular reducing compounds.39 High background activity reduced the assay sensitivity 
and introduced undesired variation, making the assay somewhat unreliable.  
(iii) Finally, we tested an induction system allowing for strong protein production in droplets from only 195 
a few cells, based on the anhydrotetracycline (aTc) inducible promoter. The inducer aTc was barely 
soluble in the fluorocarbon carrier oil (HFE-7500) and, if delivered from the oil phase, induces protein 
expression in droplets by diffusion across the phase barrier into the aqueous droplets. We could thus 
grow cells in droplets as described in the previous section, and at any chosen time point add aTc to 
the oil used for oxygenation to induce protein expression. A similar approach has recently been 200 
applied to regulate the pH inside aqueous droplets during cell cultivation by adding small amounts of 
acetic acid or diethylamine to the carrier oil phase.40 The experimentally straightforward supply of 
inducer via diffusion from the oil phase is practically convenient, does not require any additional 
droplet manipulation steps and allows for control over the total expression strength and final cell 
count (by controlling the time point of induction) compared to the other two expression methods. 205 
Crucially, the inducible promoter provided the basis for strong protein expression from few cells by 
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changing the time point of induction (Fig. 3). For an enzymatic assay (e.g. the detection of WST-1 as a 
coupled readout for enzymatic activity later in this study), high cellular background prevented the use 
of 4 h as an induction time point, which shows increased expression strength and cell growth 
compared to the used 2 h induction time point. However, we expect the achievable improvements in 210 
assay sensitivity from cell growth to be even more pronounced in assays with no cellular background, 
because the onset of stronger cell growth is easily controllable by a freely chosen induction time point. 
Consequently, this arrangement constitutes a simple and user-friendly way for induction that avoids 
an additional droplet manipulation step. 
 215 
 
Fig 3: Cell growth in droplets leads to higher protein level in each compartment. Single cells are encapsulated 
in 50 pL droplets containing growth medium and droplets are incubated for 16 h at 37°C in incubation chambers. 
Growth is performed in TB medium, except for auto-induction in ZYP-505238 medium. aTc induction is performed 
via solubilisation of 400 ng mL-1 of aTc in the oil, followed by exchange of the oil phase at different time points. 220 
Cell growth conditions are compared to a conventional single cell control, in which iLOV expression is induced 
by aTc in bulk, followed by encapsulation of single cells and direct assessment of fluorescence without any 
growth. A) Cell count (black bars) and fluorescence (green bars) of cells expressing the oxygen-independent 
fluorescent protein iLOV via different expression systems in droplets. After growth, droplets were de-emulsified 
with an antistatic gun41 and iLOV fluorescence was measured in a spectrophotometer at 475 nm/510 nm. Cell 225 
count was determined by counting colony forming units after plating the de-emulsified droplets on LB-agar. B) 
Bright field and fluorescence images of cells expressing the oxygen-independent fluorescent protein iLOV via 
different expression systems in droplets. Strong cell growth visible in the bright field image for non-induced 
control and constitutive expression. Strong fluorescence is visible for constitutive expression and aTc diffusion, 
showing the potential of high protein production from few cells via aTc diffusion. 230 
 
 
Detection and sorting of low enzyme activities 
To test the utility of the growth amplification for enzyme assays, we chose the conversion of an amino 
acid dehydrogenase (AADH) to an amine dehydrogenase (AmDH), an industrially valuable class of 235 
enzymes. AADHs can be tuned to accept an amine substrate instead of an amino acid via two active 
site mutations,42,43 but the rate of this new activity is too low to be conveniently detected. Both 
activities, however, can in principle be assayed in the same way: by detection of co-substrate 
absorbance in AADS.22 Indeed, when a well-known AmDH was used as a test case for a novel enzyme 
or an enzyme having a secondary promiscuous3–5 activity (with therefore low kcat/KM = 0.5 s-1 mM-1 42; 240 
corresponding to < 1% of the original AADH activity of kcat/KM = 71 s-1 mM-1 22), no product was 
detectable using AADS from droplets containing single cells expressing this enzyme (Fig. 4A). All 
droplets showed low absorbance, suggesting no detectable activity was apparent over background 
and single Poisson-distributed cells cannot be distinguished against droplets without a cell. The 
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minimal turnover (determined as approximately 1300 substrate turnovers per enzyme molecule or 10 245 
µM with the formazan-dye coupled absorbent assay described by Gielen et al. 22) cannot be reached 
from a single cell. In cases of low AmDH activity and limited enzyme stability, insufficient product is 
produced to be detected. This scenario makes such enzymes practically unevolvable, as the absence 
of detectable signal will thwart all selection efforts. 
In our novel workflow this situation is remedied by growing cells for 2 h at 37 °C, followed by overnight 250 
protein expression at 20 °C induced via aTc diffusion for increased protein production. To start the 
enzymatic reaction, substrate and lysis solution were added to the droplets via selective droplet 
coalescence (‘pico-fusion’, Fig. S2) after cell growth. Control of the timing of addition of these 
reagents, compared to co-encapsulation and incubation with substrate during growth, ensures a level 
playing field between all clones: the assay reaction starts at the same time for all library members, 255 
under identical conditions, minimizing non-enzymatic background reaction signal and avoiding kinetic 
complications with e.g. with the non-linearity of enzymatic time courses. The separate addition of 
reagent furthermore enables cell lysis to release intracellular enzymes and can be used to create 
reaction conditions after pico-fusion of a relatively larger volume that differs from cell growth (e.g. 
changing pH or buffer).  260 
Practically, an emulsion of 100 pL droplets with grown cells was fused with 200 pL droplets containing 
the substrate and lysis agent in the pico-fusion device. An excess of substrate and lysis solution was 
added to the cell droplet to enable efficient lysis and buffer adjustment. The enzymatic turnover of 
the substrate was measured by the absorbance of droplets of the coupled reaction product in AADS 
at multiple timepoints. Droplets containing no cells again showed low absorbance, but now there are 265 
also droplets with higher absorbance detectable, corresponding to AmDH activity (Fig. 4C). To exclude 
increased cellular background as the reason for increased absorbance in the cell growth assay, cells 
not expressing the AmDH but only containing an empty plasmid were used in the cell growth workflow 
as a control. In this case, empty droplets are not distinguishable from droplets containing cells, 
although the negative peak is wider, indicating potentially increased background activity (Fig. 4B). 270 
Thus, when the cell growth workflow is applied, activity of the AmDH becomes detectable. 
To further verify these findings, highly absorbing droplets were sorted from a 1:200 dilution of cells 
harbouring an AmDH plasmid in cells containing an empty plasmid using the cell growth workflow, 
resulting in a ~80-fold enrichment, demonstrating the utility of this workflow to detect enzymes with 
low activities. However, to make sorting possible, erroneous fusions as well as non-fused droplets 275 
must be excluded from the sorting (Fig. S3). The previously implemented sorting algorithm for AADS 
employed a simple point-over-threshold comparison,22 which was extended here to true peak 
detection (see SI for the improved Arduino sorting algorithm). This enables the sorting of a specific 
range of absorbance, as well as implementing a selection based on the signal duration that served as 




Fig. 4: Absorbance of WST-1 as a readout for enzyme activity in droplets with and without cell growth. 
Histograms show absorbance of 4000 droplets generated at an occupancy of 15%, WST-1 absorbance is 
measured at 455 nm. Absorbances greater than 0.02 are coloured blue to indicate activity above background in 285 
the single cell assay (shown in A). Arrows and percentages represent values of absorbance > 0.03, indicating 
activity above the cell growth background (shown in B), used to detect AmDH activity in enrichment experiment 
(shown in C). A) Single AmDH expressing cells are directly co-encapsulated with substrate and lysis solution. 
Absorbance of droplets is measured after 16 h of incubation. Droplets containing cells are not distinguishable 
from unoccupied droplets. B) Single cells with an empty plasmid (negative control) are encapsulated into 100 pL 290 
growth medium droplets. Cell growth is performed at 37°C for 2 h, followed by oxygenation with inductor oil 
(400 ng mL-1 aTc in HFE 7500 with 1% RAN surfactant) for 16 h at 20°C. After cell growth and protein expression, 
droplets are fused with 200 pL substrate and lysis solution. Absorbance of droplets is measured after 2 h of 
incubation to allow for enzymatic turnover. C) Single cells harbouring AmDH plasmid are treated in the cell 
growth workflow as in B). A large peak of unoccupied droplets with low absorbance is visible, as well as a tail of 295 
occupied droplets with higher absorbance due to AmDH activity, with 11.2% of all droplets corresponding 
roughly to the expected droplet occupancy. 
 
 
Quantification of improvements to sensitivity and accuracy 300 
To test whether the improvement in assay sensitivity would affect screening success, an AmDH mutant 
just active enough to be detected from single cell activity was used, so that a quantitative comparison 
between conventional and growth enhanced, clonally amplified droplets was possible, yielding an 
improvement factor. To this end, a computationally stabilized variant of the AADH was generated 
using the PROSS algorithm.44 The stabilized AADH (AADHmut, Fig. S4) shows greatly increased soluble 305 
expression (soluble fraction = 94%) compared to the non-stabilized parent AADH (soluble fraction = 
44%), at a similar level of activity (activity in cell lysate: 77% of the non-stabilized variant). The strong 
solubilization while maintaining enzyme activity achieved by the PROSS algorithm highlights the 
success of the combined strategy employed with help of the automated webserver of Goldenzweig et 
al.44: Using evolutionary precedent to reduce the false positive rate in energy calculations (and 310 
prohibiting mutations around the active site) results in strong stabilization with no change of activity. 
The stabilized AADHmut is turned into an AmDH by active site mutagenesis of residues K66X N262X, in 
analogy to the reference AmDH.42 
Single cells expressing this stabilized variant, AmDHmut, were either (i) co-encapsulated with substrate 
and lysis solution for the previously used single cell lysate assay, or (ii) encapsulated in growth medium 315 
to enable cell growth and protein expression in droplets followed by addition of substrate and lysis 
solution via pico-fusion (as described above). Product formation was measured via interrogation of 
the absorbance of the droplets in AADS at multiple time points. The average absorbance of 2500 
occupied droplets was plotted in the line graph in Fig 5A. After 0.5 h, the occupied droplets in the cell 
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growth assay reach an average detection voltage difference to the peak of unoccupied droplets of 320 
3.99 V (Fig. 5C), corresponding to ~2.5 mM reduced WST-1 indicating conversion of most of the 
available substrate (3 mM). In contrast, the activity in droplets with single cells start plateauing after 
2 h at an average detection voltage difference of 1.32 V (corresponding to ~1.1 mM reduced WST-1; 
Fig. 5B)). Consequently, using the cell growth assay the initial rate of product formation by AmDHmut 
is 12.1-fold increased compared to the single cell assay. 325 
The distribution of the measured absorbance values for an identical clone in many droplets made it 
immediately obvious that the cell growth workflow not only increases the signal strength, but also 
decreases signal variation over the single cell assay (Fig. 5D). The peaks of occupied droplets showed 
5 to 15% relative standard deviation, compared to 20 to 25% for the single cell assay. By comparison, 
the variation in the assay was at least reduced by half as a consequence of measuring activity of a 330 
population of cells rather than a single cell in each droplet (Fig. 5D). When multiple cells are 
responsible for protein production, the idiosyncratic or stochastic effects of single cells are averaged, 
resulting in a more reliable and consistent signal. 
 
 335 
Fig. 5: Quantification of growth effects. A) Difference in absorbance detection signal of the peak of occupied 
droplets and unoccupied droplet peak for a stabilized AmDH in single cell (dashed line) and cell growth assay 
(solid line). Average calculated from 2500 detected droplets, error bars show standard deviation. B) Histogram 
(n = 2500) of the absorbance of droplets containing single stabilized AmDH expressing cells co-encapsulated with 
substrate and lysis solution after 4 h of incubation. A peak of unoccupied droplets with low absorbance can 340 
clearly be separated from a peak of droplets containing single cells. C) Histogram (n = 650) of the absorbance of 
droplets containing approximately 20-30 cells grown in droplets and expressing the stabilized AmDH. 
Absorbance measured 30 minutes after addition of substrate and lysis agent to the droplets. D) Comparison of 
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variation in the in-droplet cell growth (blue) and single cell workflows (green). The detection signal of the 
occupied droplet peak was isolated and normalized to have a mean of one. Chosen time points are 4 h for single 345 
cell assay (22.7% relative standard deviation, fully shown in panel B) and 30 min for cell growth (10.7% relative 




The new workflow achieves an increase in the detection limit, sensitivity and recovery efficiency of 
microdroplet-based screening of enzyme libraries and delivers the following: 
(i) A device for droplet incubation in a densely filled chamber. Emulsions are incubated in modified 
commercial 0.5 mL reaction tubes requiring no additional equipment, in a much simpler set-up and 
higher throughput compared to the more complicated devices used previously for cell biological 355 
analysis45 or for metagenomic screening.33 Incubation in the modified chamber results in tightly 
packed emulsions by passively draining the excess oil phase left from droplet generation, providing 
the large numbers and stability necessary for prolonged screening campaigns. Droplets can easily be 
withdrawn for analysis or manipulation and returned for incubation under oxygenating conditions. 
Oxygenation by oil perfusion resulted high growth rates and crucially homogeneous populations. 360 
(ii) Passive delivery of assay component via the oil phase. Supplying each droplet continuously via the 
oil flow with oxygen leads to faster cell growth and growth homogeneity in all droplets. Supplementing 
the oil additionally with the inducer aTc switches on protein expression, allowing separate timescales 
for cell growth and expression (e.g. for proteins that are toxic or assays with high cellular background). 
By clonal amplification more enzyme molecules are produced per droplet, leading to a higher product 365 
signal and easier detection.  
(iii) Active delivery of assay components via droplet manipulation. Controlled addition of substrate and 
lysis reagents by pico-fusion of droplets permits precise timing of the reaction start, so that the 
optimal ratio of signal generated by the enzymatic reaction to noise of the uncatalysed background 
reactions can be chosen. This increases the dynamic range for reactions with high chemical 370 
backgrounds. Furthermore, the buffer composition for reaction is adjusted from the cell growth 
medium in this step, widening the scope of detectable reactions and allowing cell lysis to release 
intracellularly expressed enzymes. 
(iv) Clonal amplification multiplies the product readout. Cell growth leads to more expressed enzyme, 
which, after catalytic turnover, leads to more product generated per droplet compartment. Here, we 375 
demonstrated in an absorbance assay in droplets22 that the detection limit (of originally 1300 
turnovers per enzyme molecule) could be reduced to ~100 molecules per enzyme molecule. This 
improvement was based on the observed 12-fold increase in reaction rate brought about by more 
available enzyme after expression by multiple cells. It may be possible to grow even larger number of 
cells to achieve larger amplification factors, potentially resulting in up to 48-fold improvements (based 380 
on quantification of GFP expression, see Fig. 3). It will also be possible to grow cells displaying proteins, 
e.g. using droplet-compartmentalised E. coli autodisplay46 or yeast display20, instead of cell growth 
combined with lysis to liberate intracellular protein as demonstrated here.  
(v) Increased precision of droplet enzymatic assays. Differential protein expression levels per cell 
(phenotypic variation) and variability in the time of lysis in single cell assays and have been suggested 385 
as sources for droplet-to-droplet variation.47,48 This variation is reduced here by averaging a population 
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of cells, potentially decreasing the number of false positives and allowing the detection of more 
genuine hits. This idea had been considered before,28,32 but was never quantified and is achieved here 
for the first time for enzyme activity. This advance is not only a general improvement of the reliability 
and efficiency of droplet screening, but also could prove useful for applications such as deep 390 
mutational scanning, in which quantitative measures of variant frequencies rely on oversampling and 
rediscovering the same variant multiple times in distinct gates.49  
(vi) Enhanced recovery efficiency. Enhanced recovery efficiency is brought about by an increased 
number of genetic elements after cell multiplication. After sorting, selected droplets are de-emulsified 
and the plasmid DNA is isolated for subsequent cell transformation. In case of single cell droplet 395 
assays, the recovery efficiency is low, as the amount of plasmid from one cell is not always enough to 
produce a transformant. In the first study on single cell lysate droplet assays, Kintses et al. describe a 
theoretical single cell recovery efficiency of 87% with an ultra-high copy plasmid.19 In the case of cell 
growth in droplets, the transformation of sorted DNA usually yielded between 10 and 100 times the 
number of sorted droplets, depending on the actual cell count within the droplet, thus recovering all 400 
sorted variants with an up to 100-fold higher chance even with the medium-high copy aTc-inducible 
plasmid. 
 
Taken together, this workflow increases the sensitivity of droplet enzymatic assays by several orders 
of magnitude, making catalyst discovery campaigns more likely to be successful. While an increasing 405 
number of catalyst screens in droplets have been successfully implemented,50 some approaches 
categorically require higher sensitivity to meet success. The successful detection of a weak 
promiscuous activity that remained undetectable (and thus unselectable) without clonal amplification 
by cell growth was demonstrated in this work in selections of an AADH for its weaker AmDH activity 
as a paradigm for adaptive evolution of promiscuous reaction. Likewise, metagenomic screenings will 410 
detect larger numbers of catalysts as here the low expression efficiency from metagenomic DNA in 
heterologous hosts (and often in the absence of a useful promotor) is a typical challenge that ‘hides’ 
interesting novel enzymes.  
Alternative detection modes beyond fluorescence and absorbance, such as e.g. electrochemistry24 or 
mass spectrometry25 would be useful to enlarge the types of assays (i.e. more substrate and reaction 415 
types) to be conducted in droplets, but suffer from low sensitivity. For example, it has not been 
possible to carry out selections in a monoclonal manner using mass spectrometry, likely due to the 
requirement of very high total turnover numbers owing to the combination of comparably high 
detection limits (30 µM) and large droplets (25 nL).25 Assuming a similar expression efficiency as seen 
by Gielen et al., a single cell would provide ~8 × 105 enzyme molecules to a droplet,22 requiring each 420 
enzyme molecule to turn over 22,600 or 565,000 substrate molecules to reach detection limit in 
electrochemical24 or mass spectrometric25 detection, respectively. An increased supply of enzyme to 
the droplet via the workflow presented here may pave the ground for better versatility of droplet 
microfluidics by opening up prospects for these new detection modes. 
More generally, reliable recovery of unstable, poorly expressed or inactive enzyme variants and 425 
biocatalysts will be especially relevant in bioprospecting of novel biocatalysts in functional 
metagenomics or for engineering new functions into enzymes in the early stages of directed evolution. 
An order of magnitude gain in sensitivity, increasing the number of genuine positive (while decreasing 
false positives by averaging the readout from multiple cells), enhancing the utility of new assay 
technologies, a 100-fold better recovery and control over assay timing will reveal catalysts that are 430 
currently orders of magnitude short of being detectable. The capacity to detect additional catalytic 
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sequences will no doubt enable more adventurous and challenging bioprospecting and protein 
engineering campaigns in the future and bring ultrahigh throughput droplet microfluidic screening 
closer to being a mainstay of combinatorial biochemistry and biotechnology.  




All chemicals and oligonucleotides were purchased from Sigma-Aldrich unless noted otherwise. 
Enzymes were purchased from New England Biolabs. The plasmid pASK-IBA36b+ was purchased from 
IBA lifesciences, the plasmid pRSF-Duet1 from Novagen. The 008-FluoroSurfactant was purchased 440 
from RAN biotechnologies. 
Microfluidic chip fabrication 
Microfluidic chips were designed with AutoCAD 2018 and fabricated using standard soft lithography 
procedures.51 Silicon wafers (3 inch diameter, Siegert Wafer) were coated with photoresist (SU-8 2050, 
Microchem) and patterned by exposure to UV light through a printed photomask. 445 
Polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning) imprints were bonded to glass slides after 
surface plasma treatment and channels were made hydrophobic by flushing with 1% 
Trichloro(1H,1H,2H,2H-perfluorooctyl)silane in HFE-7500 (3M Novec). 
Plasmid preparation 
The oxygen-independent fluorescent protein iLOV was ordered from Addgene in a pET28a plasmid 450 
under control of a T7 promoter (plasmid #63723). The iLOV gene was cloned into pASK-IBA36b+ for 
aTc inducible expression via Gibson assembly. For constitutive expression, the iLOV gene was cloned 
to replace the lacI gene in a reduced pRSF-Duet1 plasmid, thus being under control of the placI 
promoter. The pRSF-Duet1 plasmid was modified before to remove the two original T7 promoter sites 
by amplification via inverse PCR from T7 terminator to T7 promoter, followed by intramolecular 455 
ligation. The Rhodococcus sp. M4 phenylalanine dehydrogenase (Uniprot ID Q59771) with AmDH 
mutations as determined by Ye et al.42 was ordered as a gene string and cloned into pASK-IBA63b+ for 
aTc inducible expression. The origin of replication for this plasmid is a medium-high copy ColE1 
derivate. 
Cell growth in droplets and comparison of induction conditions 460 
Droplet incubation chambers were built as described in the SI. For cell growth, droplets were generally 
incubated under oil flow to achieve mixing and oxygenation. HFE-7500 with 1% 008-FluoroSurfactant 
was pushed through the droplet incubation chamber at 4 µl/min per 100 µl of droplet emulsion. To 
quantify the cell growth in comparison to non-oxygenated incubation, a 15 mM WST-1 solution was 
added to the droplets via pico-fusion (Fig. S2). WST-1 detects NADH from live cells and can be 465 
measured in AADS as described previously.22 For comparison of induction conditions, iLOV expressing 
E. coli BL21 (DE3) cells were grown in different expression conditions. Autoinduction was performed 
by growth in ZYP-5052 medium.38 Growth for all other expression conditions was performed in TB 
medium (12 g/l tryptone, 24 g/l yeast extract, 5 g/l glycerol, 2.3 g/l KH2PO4, 12.5 g/l K2HPO4). Induction 
via aTc was performed by solubilizing 400 ng/mL aTc in the carrier oil. After growth and protein 470 
expression, droplets were de-emulsified with an antistatic gun41 and iLOV fluorescence was measured 
in a spectrophotometer at 475 nm/510 nm. Cell count was determined by counting colony forming 
units after plating the de-emulsified droplets on LB-agar. 
Enzyme assay from single cell lysate in droplets 
Single cell lysate assays are performed similarly to the published droplet assay for phenylalanine 475 
dehydrogenases (PheDH), except that a substrate for amine dehydrogenases (AmDH) is used.22 After 
transformation of E. coli BL21 (DE3), all colonies are washed off the agar plate with 3 mL of LB medium. 
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This stock is used to inoculate 4 mL fresh LB in a sterile culture tube to an optical density at 600 nm 
(OD600) of 0.8. To this culture, inducer is immediately added (200 ng/ml aTc (Acros Organics)) and it is 
incubated overnight shaking (200 rpm) at 20°C for protein expression. After expression, the OD600 is 480 
measured again and the cells are washed and diluted with encapsulation buffer (25% (v/v) Percoll in 
100 mM glycine-KOH pH 9). Dilution is based on the assumption that for E. coli BL21, an OD600 of 1 is 
equalling approximately 5 x 108 cells/ml, aiming to enable droplet occupancies of 0.25 cells per droplet 
in order to avoid excess double encapsulations. The cell solution, the substrate and lysis solution 
(6 mM WST-1 (NBS Biologicals), 6 mM R-1-methyl-3-phenylpropylamine, 2 mM NAD+, 5 µg/ml 1-485 
methoxy-5-methylphenazinium methyl sulfate (mPMS), 1 µl/ml rLysozyme (Merck) and 0.8x CelLytic 
B in 100 mM glycine-KOH pH 9) and the oil phase (HFE-7500 with 1% 008-FluoroSurfactant) are drawn 
up into syringes. A conventional droplet generator (80 µm height and 50 µm width at the flow-focusing 
junction) was used to generate 300 pl droplets at high frequency (> 1 kHz) with flow rates of 30 µl/min 
oil and 8 µl/min for each of the two aqueous phases. The emulsion is incubated at 22°C, absorbance 490 
is measured and droplets are sorted as described in Gielen et al.22 
Enzyme assays after cell growth in originally monoclonal droplets 
A non-induced cell solution is prepared and diluted as in the early steps of the single cell lysate assay. 
A conventional droplet generator (50 µm height and 50 µm width at the flow-focusing junction) was 
used to generate 100 pl droplets at high frequency (> 1 kHz) with flow rates of 24 µl/min oil (HFE-7500 495 
with 1% 008-FluoroSurfactant) and 8 µl/min diluted cell solution. Droplets are collected in an 
incubation chamber and grown as described above. For induction of protein expression with aTc, the 
droplets were oxygenated and incubated at 37°C for 1 h. The oil phase was then changed to inducer 
oil (HFE-7500 with 1% 008-FluoroSurfactant and 400 ng/ml aTc). Inducer oil was pushed for 10 min at 
10 µl/min from the top to quickly exchange to oil in the emulsion and then used for oxygenation at 4 500 
µl/min overnight at 20°C. After cell growth, the emulsion was injected into the pico-fusion chip (Fig. 
S2). Droplets were injected at 1 µl/min and spaced with HFE-7500 flowing at 1.5 µl/min. A flow-
focusing junction on the same chip (50 µm width, 50 µm height) was used to generate 200 pl droplets 
of substrate and lysis solution (4.5 mM WST-1, 4.5 mM R-1-methyl-3-phenylpropylamine, 3 mM NAD+, 
7.5 µg/ml mPMS, 200 µg/ml streptomycin, 2 µl/ml rLysozyme and 0.6x CelLytic B in 100 mM glycine-505 
KOH pH 9). If droplets were incubated for sorting, 4 mM tartrazine were added in the substrate and 
lysis solution as an absorbant offset. Substrate and lysis droplets were generated with an aqueous 
flow rate of 2 µl/min and oil (HFE-7500 with 1% 008-FluoroSurfactant) at 3 µl/min. The injected 
droplets with grown cells and the generated substrate droplets are synchronized in the delay channel 
by slight adjustments to the droplet re-injection flow rate. The smaller cell droplets pack behind the 510 
larger substrate droplets in the delay channel, before entering the fusion chamber. An electric field of 
400V and 10 kHz is applied on salt water electrodes52 to facilitate droplet coalescence. Fused droplets 
are collected and incubated in an incubation chamber before injection into a sorting chip to measure 
absorbance and select droplets with increased absorbance, as described by Gielen et al.22 Videos of 
droplet coalescence and droplet sorting are attached in the ESI. 515 
Verification of activities in plate screening 
Identity of sorted variants was confirmed in a secondary screening in 96-well plates. Transformed 
colonies after sorting were used to inoculate 400 µl LB medium in a 96-well deep well plate. After 
initial growth overnight at 37°C, 25 µl of this culture were used to inoculate 425 µl fresh LB medium. 
After 2 h of growth, 50 µl LB with 10x aTc (2 µg/ml) was added for induction of protein expression, 520 
which was performed at 20°C overnight. Cells were pelleted (20 min at 3220 x g) and lysed (200 µl 
25 mM Tris-HC pH 8, 0.1% triton X-100, 1 µl/30 ml benzonase (Merck)). In a new plate, the detection 
reaction was started by adding substrate solution (10 mM R-1-methyl-3-phenylpropylamine, 2 mM 
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NAD+ in 100 mM Glycine-KOH pH 9) to 20 µl of the cell lysate. Reaction progress was monitored as 
increase in absorbance at 340 nm for 5 min. 525 
Generation of a stabilized AmDH 
The PROSS algorithm44 was used to generate stabilized designs of the parental AADH, based on its 
crystal structure (PDB ID 1C1D). The active site (all residues less than 8 Å away from either substrate 
L-phenylalanine and NAD+) was excluded from alteration. Six designs were synthesised (Geneart) and 
tested. The design showing the highest expression strength and activity was chosen for further 530 
experiments (Supplementary sequence 1). Soluble expression was determined via gel densitometry in 
ImageJ Fiji after SDS-PAGE separation of the clarified lysate and pellet fraction (Fig. S4A) of an 
expression culture grown and lysed as described above. Activity was tested in lysate assays relative to 
the non-stabilized variant, as described above (Fig. S4B). The fourth design (Pross 4, Supplementary 
sequence 1) was chosen to be turned into an AmDH as it showed the highest soluble expression 535 
strength. AmDHmut was generated from this stabilized AADH by introduction of mutations K66X N262X 
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